Exclusive: Questionable Data Propped Up Cancer Drug Provenge
Exclusive: Questionable data propped up cancer drug Provenge
Filed under: drug treatment news 2010
The U.S. Food and Drug Administration also stood by its April 2010 decision to approve the treatment. But the disclosure could mark another setback for Dendreon, whose market value has tumbled over 70 percent in the past eight months after …
Read more on Chicago Tribune
Addiction plays role in state's deadly diagnosis
Filed under: drug treatment news 2010
In fact, a 2012 report from the West Virginia Department of Health and Human Resources states prescription drug overdoses increased from 2001-2010. The Centers for Disease Control and Prevention showed the Mountain State had the second highest rate …
Read more on State Journal
Rehab for drug addicted kids as local cases almost treble
Filed under: drug treatment news 2010
A total of 61 children (classed as 17 or under) are currently being treated for addictions in the Southern health board area which includes Dungannon District, increasing from 21 in 2010. Alarmingly, 41 of the children are trying to beat an addiction …
Read more on Tyrone Times
More drug treatment news 2010 Resources
Exclusive: Questionable Data Propped Up Cancer Drug Provenge
NEW YORK (Reuters) – In Dendreon Corp's most important clinical trial for the controversial cancer therapy Provenge, researchers analyzed some of the data differently from how the company told U.S. regulators they would, according to documents reviewed by Reuters. That not only was a departure from scientific norms, but also artificially inflated the apparent benefit of the prostate cancer … Read News